Healios KK (HLOSF)
0.965
-0.03
(-2.86%)
USD |
OTCM |
May 17, 09:30
Healios Cash from Financing (Quarterly): 14.90M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.90M |
| December 31, 2023 | -10.67M |
| September 30, 2023 | 25.48M |
| June 30, 2023 | 0.946M |
| March 31, 2023 | 8.025M |
| December 31, 2022 | 7.097M |
| September 30, 2022 | -28.28M |
| June 30, 2022 | 2.026M |
| March 31, 2022 | -0.0344M |
| December 31, 2021 | 3.054M |
| September 30, 2021 | 61.17M |
| Date | Value |
|---|---|
| June 30, 2021 | -0.2466M |
| March 31, 2021 | -0.2833M |
| December 31, 2020 | 5.931M |
| September 30, 2020 | 1.351M |
| June 30, 2020 | -0.3461M |
| March 31, 2020 | 0.5877M |
| December 31, 2019 | -2.434M |
| September 30, 2019 | 108.19M |
| June 30, 2019 | -0.5467M |
| March 31, 2019 | -0.3996M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-28.28M
Minimum
Sep 2022
108.19M
Maximum
Sep 2019
9.796M
Average
1.148M
Median
Cash from Financing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -450.06M |
| Nxera Pharma Co Ltd | -12.29M |
| PeptiDream Inc | -5.103M |
| AnGes Inc | -- |
| SanBio Co Ltd | -- |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.144M |
| Cash from Investing (Quarterly) | -2.480M |
| Free Cash Flow | -19.34M |
| Free Cash Flow Per Share (Quarterly) | -0.0501 |
| Free Cash Flow to Equity (Quarterly) | -2.163M |
| Free Cash Flow to Firm (Quarterly) | 5.316M |
| Free Cash Flow Yield | -27.48% |